NCT05084924View on ClinicalTrials.gov

Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Major Depressive DisorderAnhedonia
Interventions
DEVICE

Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus

Stimulation will be delivered via the NeuroConn Direct Current Stimulator Plus, an investigational electrical non-invasive brain stimulation device that is being used for foundational neuroscience and translational research.

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT05084924 - Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia | Biotech Hunter | Biotech Hunter